Heart Disease Trial, Recruiting NCT06969560 Sponsor: University of Alberta Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06969560
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers between 8 and 18 years old who are being seen as outpatients (not currently admitted to hospital) at the time of joining the study.
  • People with a chest measurement of at least 69.85 cm around the chest, measured just below the chest muscles.
  • People who are at risk of heart failure or have been diagnosed with heart failure at certain stages (American Heart Association Stage B, C, or D), regardless of whether they are taking heart failure medications.
  • People whose heart failure is caused by a range of conditions, including heart defects present from birth, cardiomyopathy (various types), a history of heart muscle inflammation, muscular disorders, certain metabolic or mitochondrial conditions, treatment-related causes (such as chemotherapy), infection or rheumatic conditions, Kawasaki disease, or specific structural heart conditions (confirm with trial site for exact diagnosis eligibility).

Who may not be able to join:

  • People who have had surgery within the past 3 months.
  • People who are currently using a mechanical heart pump (ventricular assist device) at the time of joining.
  • People who are unable to use technology due to a physical or cognitive difficulty, including cases where the caregiver also faces this difficulty.
  • People who do not speak English.
  • People who have an implanted heart defibrillator or pacemaker.
  • People whose chest size falls outside the range that fits the available sizes of the wearable device used in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer L Conway, MD, MSc, University of Alberta/Stollery Children's Hospital

Phone: 780-407-4848

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 February 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility of Remote Physiologic Monitoring (RPM) Program- Recruitment; Feasibility of Remote Physiologic Monitoring (RPM) Program- Retention; Feasibility of Remote Physiologic Monitoring (RPM) Program- Access; Acceptability of Remote Physiologic Monitoring (RPM) Program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov